- Home
- NERV vs GTIM Comparison
NERV vs GTIM Comparison
Compare NERV & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- GTIM
- Stock Information
- Founded
- NERV 2007
- GTIM 1987
- Country
- NERV United States
- GTIM United States
- Employees
- NERV N/A
- GTIM N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- GTIM Restaurants
- Sector
- NERV Health Care
- GTIM Consumer Discretionary
- Exchange
- NERV Nasdaq
- GTIM Nasdaq
- Market Cap
- NERV 14.6M
- GTIM 13.6M
- IPO Year
- NERV 2014
- GTIM 1990
- Fundamental
- Price
- NERV $3.78
- GTIM $1.30
- Analyst Decision
- NERV Hold
- GTIM
- Analyst Count
- NERV 1
- GTIM 0
- Target Price
- NERV $4.00
- GTIM N/A
- AVG Volume (30 Days)
- NERV 101.0K
- GTIM 71.1K
- Earning Date
- NERV 11-05-2025
- GTIM 12-11-2025
- Dividend Yield
- NERV N/A
- GTIM N/A
- EPS Growth
- NERV N/A
- GTIM 17.03
- EPS
- NERV N/A
- GTIM 0.12
- Revenue
- NERV N/A
- GTIM $143,398,000.00
- Revenue This Year
- NERV N/A
- GTIM N/A
- Revenue Next Year
- NERV N/A
- GTIM N/A
- P/E Ratio
- NERV N/A
- GTIM $10.69
- Revenue Growth
- NERV N/A
- GTIM 1.78
- 52 Week Low
- NERV $1.15
- GTIM $1.17
- 52 Week High
- NERV $12.46
- GTIM $2.90
- Technical
- Relative Strength Index (RSI)
- NERV 49.13
- GTIM 39.89
- Support Level
- NERV $3.76
- GTIM $1.23
- Resistance Level
- NERV $4.42
- GTIM $1.31
- Average True Range (ATR)
- NERV 0.32
- GTIM 0.08
- MACD
- NERV -0.09
- GTIM 0.00
- Stochastic Oscillator
- NERV 25.93
- GTIM 47.21
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.